Panels

In the Trenches with Tranches: Financing Strategies for Growth Access to capital is not a new issue to biotech.  It’s the issue and has been since the beginning.  And today, it’s not even a question of whether new ways to access capital are needed; they are a necessity.  There are new ideas out there, but which… Read the full article



Press Releases and Media Contacts

Press Releases BioNJ’s First New Jersey Life Sciences CEO Summit Promises to ‘Take It to the Top’ in October BioNJ CEO Summit to Feature Executive Leadership from Major Biotech and Pharmaceutical Companies TRENTON, NJ (June 19, 2013) – Working from the theme “Take It to the Top,” BioNJ will bring together chief executive officers (CEO) and leaders… Read the full article


Committee of Volunteers

Chairman Al Altomari Agile Therapeutics Vice Chairman Jan Campbell Korn/Ferry Committee Gil Bashe Makovsy + Co. Michael Becker MDB Communications Greg Coir Randstad Robert Esposito EisnerAmper Fred Feiner Yankee Public Relations Michael Hadjiloucas EisnerAmper PJ Kim ABL Inc. Stephanie Koenig Campbell Alliance Christian Kopfli Chromocell Corporation Nanette Mantell Reed Smith Jim Marino Dechert LLP Chris… Read the full article


Executive Suite Sponsors

Chairman Level CEO Level   President Level   Executive Level Board Level Executive Vice President Level   Vice President, Corporate Communications Level CEO Summit Branding CEO Summit Photography CEO Summit Animation CEO Summit Public Relations CEO Summit Talent Executive Suite Sponsorship Opportunities are Still Available Please contact Kathleen Otto at KOtto@BioNJ.org or 609-890-3185 for more… Read the full article


Featured Speakers Keynotes Luncheon Keynote Robert J. Hugin Chairman and CEO Celgene Corporation Morning Keynotes Andre Wyss US Country Head, President Novartis Corporation and President Novartis Pharmaceuticals Corporation John F. Crowley Chairman and CEO Amicus Therapeutics, Inc. Afternoon Keynote Tony Gibney Managing Director Leerink Swann LLC Reception, Dinner and Fireside Chat on the Evening of… Read the full article


BioNJ Board of Trustees Host Committee

  Chairman Francois Nader, M.D. President and Chief Executive Officer NPS Pharmaceuticals, Inc. Immediate Past Chair Sol J. Barer, Ph.D. Former Chairman Celgene Corporation President and CEO Debbie Hart President and CEO BioNJ Vice Chairman Christopher J. Schaber, Ph.D. President and Chief Executive Officer Soligenix, Inc. Secretary Donna Tempel, Ph.D., MBA President and Chief Executive… Read the full article


Program

  Friday, October 4, 2013  7:00 a.m. – 7:45 a.m. Registration and Networking Breakfast Buffet 7:45 a.m. – 8:00 a.m. Welcome 8:00 a.m. – 9:00 a.m. Panel – In the Trenches with Tranches: Financing Strategies for Growth Lorenzo Pellegrini, Ph.D. Partner Care Capital, LLC Stuart Peltz, Ph.D. CEO PTC Therapeutics, Inc. Chris Tyrrell CEO OfferBoard… Read the full article


BioNJ Debuts Inaugural CEO Summit: Take It to the Top October 4, 2013 Bridgewater Marriott Bridgewater, New Jersey   Join us in the Executive Suite as we “Take It to the Top.” On October 4th, BioNJ will bring together CEOs and leaders from major biotech and pharmaceutical firms from New Jersey and beyond to share… Read the full article